🍪 The GLP Lounge uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsClinical Trials & ResearchInsulin icodec (Awiqli) — need advice Page 7

Insulin icodec (Awiqli) — need advice

VendorMark Mon, Feb 2, 2026 at 1:53 AM 31 replies 1,494 viewsPage 7 of 7
InsuranceTom
Senior Member
1,345
7,890
Mar 2024
Connecticut
Feb 11, 2026 at 10:51 AM#31
NurseKim_ATL said:
It helps to say which part of this you are uncertain about.

There is a second half to this that has not been said yet. If two explanations both fit, the useful question is which one predicts something the other does not. That is answerable; arguing about which sounds more plausible is not.

Last edited: Feb 11, 2026 at 3:51 PM
32 5lisa_labSD, adam_van, Dr.SurgeonPGH and 29 others
Reply Quote Save Share Report
Dr.PulmRoch
Member
456
2,345
Jun 2024
Rochester, MN
Feb 12, 2026 at 2:13 AM#32

The figures, for anyone assembling their own picture. Give anything pharmacological four weeks before you judge it, and give anything measured weekly a four-point rolling average before you call it a trend.

33 6traveltech_sara, AttorneyGrant, DebRD_ATL and 30 others
Reply Quote Save Share Report
traveltech_sara
Member
156
678
Jan 2025
Remote, USA
Feb 12, 2026 at 5:35 PM#33

Following on from NurseKim_ATL — and this may be the naive question:

How long did you give it before you decided it was working?

34 7wanda_boise, NurseAsh_DET, BenResearch_OR and 31 others
Reply Quote Save Share Report

Sigma-Aldrich — Research-Grade Standards

Certified reference materials, analytical reagents, and research-grade standards for peptide verification. Trusted by laboratories worldwide.

Shop Reference Standards
kim_atl_prep
Member
312
1,345
Aug 2024
Atlanta, GA
Feb 13, 2026 at 8:56 AM#34
Dr.PulmRoch said:
Give anything pharmacological four weeks before you judge it, and give anything measured weekly a four-point rolling average before you call it a…

I am going to disagree with the direction of travel here. The thread has converged on the tidiest answer rather than the best-supported one, and those are not the same thing.

35 8SleepDoc_PDX, RegAffairsDC, BiostatsBrad and 32 others
Reply Quote Save Share Report
emily_PDX
Member
245
1,123
Nov 2024
Portland, OR
Feb 14, 2026 at 12:17 AM#35
Dr.PulmRoch said:
Give anything pharmacological four weeks before you judge it, and give anything measured weekly a four-point rolling average before you call it a…

Fair, and it stops being fair at the extremes. The middle of the range is well understood; the ends are where the honest answer is that nobody knows.

Last edited: Feb 14, 2026 at 2:17 AM
36 9PeptideSynthNJ, Dr.KarenChen, Dr.NateNeph and 33 others
Reply Quote Save Share Report
1567

Similar Threads

FLOW trial: semaglutide renal outcomes — NEJM publication review14 replies
SELECT trial: semaglutide 2.4mg cardiovascular outcomes — 4yr data9 replies
TRIUMPH program (retatrutide) — Phase 3 trial design and endpoints13 replies
Orforglipron ATTAIN trials — oral non-peptide GLP-1 agonist8 replies
CagriSema (amylin + semaglutide) — REDEFINE Phase 3 results20 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register